December 30, 2024

Gene Therapy May Help Motor Function in SMA

"Maintaining motor function is a key goal for many older patients with SMA."

Reuters

December 30, 2024

Axsome Pursues Approval for Agitation Drug

Axsome Therapeutics seeks marketing approval for its oral drug targeting agitation in Alzheimer's patients, showing promising results in late-stage studies.

Reuters

December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 23, 2024

Trump Team Targets Immediate WHO Exit, Experts Say

"I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration."

Reuters

December 19, 2024

Vertex Pain Drug Falls Short vs. Placebo

Vertex Pharmaceuticals' non-opioid drug, suzetrigine, showed little difference versus a placebo in reducing pain for lumbosacral radiculopathy, prompting FDA review for treating moderate-to-severe acute pain.

Reuters

December 18, 2024

USPSTF Challenges Common Supplement Use

"Unfortunately, when we reviewed the latest evidence, we found that taking vitamin D with or without calcium does not prevent falls or fractures in older adults."

Conexiant

December 18, 2024

Does Anger at Health Care Drive Change?

In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.

KFF Health News

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant